EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Economic impact of ovarian stimulation antagonist protocol vs primed progesterone protocol in oocyte donor program: a retrospective study

Josep Gonzalo, Camil Castelo-Branco, Sandra Garcia, Marta Devesa, Nikolaos P. Polyzos

European Gynecology & Obstetrics · 27.12.2024 · 6 (3)

DOI: 10.53260/ego.246033 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift European Gynecology & Obstetrics, online erschienen am 27.12.2024. Verfasst von Josep Gonzalo und 4 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To assess the cost-effectiveness of two ovarian stimulation procedures comparing the use of FSH antagonists with the use of FSH progestin primed controlled ovarian stimulation in an oocyte donor program.

Design

To calculate cost-effectiveness ratios (costs per outcome achieved) from clinical practices using a retrospective cohort single university center study carried out from 2012 to 2021.Main outcome measure(s): Cost-effectiveness ratios as cost per mature oocyte and cost per treatment.

Results

According to the economic analysis, ovarian stimulation with FSH antagonist protocol increased statistically significantly the overall cost of the treatment as well as the cost per retrieved and effective oocyte. The cost of gonadotrophins per mature oocyte retrieved was 49.27 ± 17.94 € and the cost of medication per mature retrieved oocyte was 59.26 ± 28.01 €. In the FSH primed progesterone group, the cost of gonadotrophins per mature retrieved oocyte was 44.67 ± 16.65 € and the cost of medication per mature retrieved oocyte retrieved 44.91 ± 20.86 €.

Conclusion

Cost-effectiveness is a compelling reason for an egg donation program. Progestins can present an effective and less expensive option for egg donation programs in terms of cost.

Zitieren

APA

Gonzalo, J., Castelo-Branco, C., Garcia, S., Devesa, M., & Polyzos, N. P. (2024). Economic impact of ovarian stimulation antagonist protocol vs primed progesterone protocol in oocyte donor program: a retrospective study. European Gynecology & Obstetrics, 6(3). https://doi.org/10.53260/ego.246033

Vancouver

Gonzalo J, Castelo-Branco C, Garcia S, Devesa M, Polyzos NP. Economic impact of ovarian stimulation antagonist protocol vs primed progesterone protocol in oocyte donor program: a retrospective study. European Gynecology & Obstetrics. 2024;6(3). doi:10.53260/ego.246033

BibTeX
@article{Gonzalo2024,
  author = {Gonzalo, Josep and Castelo-Branco, Camil and Garcia, Sandra and Devesa, Marta and Polyzos, Nikolaos P.},
  title = {Economic impact of ovarian stimulation antagonist protocol vs primed progesterone protocol in oocyte donor program: a retrospective study},
  journal = {European Gynecology & Obstetrics},
  year = {2024},
  volume = {6},
  number = {3},
  doi = {10.53260/ego.246033}
}
Kostenlos starten →